RxDoctor Payments Data

Melissa Johnson, DO

Family Medicine · Fenton, MONPI 1548284896

Payments from drug & device makers

$2,061in general payments, 2019–2025

Across 121 payments — averaging $17.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$735
  • Pfizer$193
  • Lilly USA, LLC$167
  • Johnson & Johnson$163
  • Novo Nordisk$160
  • Amgen$122
  • plus $521 from 17 others

What the payments were for

  • Food & beverage$2,02498%
  • Education$171%
  • Entertainment$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,061 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$30,099
Medicare patients
80
Services billed
519

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide129$163,368
EliquisApixaban78$56,049
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$48,305
JardianceEmpagliflozin36$45,554
MounjaroTirzepatide29$41,414
XareltoRivaroxaban28$38,519
TrulicityDulaglutide20$28,813
MyrbetriqMirabegron28$28,532
ProliaDenosumab14$23,994
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr33$23,404
Nurtec OdtRimegepant Sulfate13$20,545
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$16,712
ArexvyRsvpref3 Antigen/As01e/Pf61$16,243
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$12,988
Semglee (Yfgn) PenInsulin Glargine-Yfgn21$7,645

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$160$163,368129 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arexvy, Breo Ellipta$47$93,382158 claims
PfizerEliquis, Nurtec Odt$193$76,59491 claims
Lilly USA, LLCMounjaro, Trulicity$167$70,22749 claims
Boehringer IngelheimJardiance$62$45,55436 claims
Johnson & JohnsonXarelto$163$38,51928 claims
Astellas Pharma US IncMyrbetriq$38$28,53228 claims
AmgenProlia$122$23,99414 claims
AstraZenecaBreztri Aerosphere$100$16,71215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Fenton

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →